INDV

Indivior Plc

Sep 15 • 04:00PM ET

23.19

-0.01 -0.06 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Peers: JNJ VRTX PFE ABBV BMY GILD LLY BIIB TEVA NBIX

| Held by: IWM IWO VTWO IWN VTWG VT PSC RSSL GWX FHLC

Index	RUT	P/E	32.72	EPS (ttm)	0.71	Insider Own	11.92%	Shs Outstand	125.00M	Perf Week	-6.24%
Market Cap	2.89B	Forward P/E	11.41	EPS next Y	2.03	Insider Trans	0.00%	Shs Float	109.89M	Perf Month	0.11%
Enterprise Value	2.75B	PEG	2.78	EPS next Q	0.39	Inst Own	91.87%	Short Float	7.11%	Perf Quarter	66.99%
Income	89.00M	P/S	2.47	EPS this Y	4.22%	Inst Trans	8.74%	Short Ratio	2.68	Perf Half Y	139.62%
Sales	1.17B	P/B	-	EPS next Y	17.53%	ROA	5.96%	Short Interest	7.82M	Perf YTD	86.60%
Book/sh	-2.06	P/C	5.67	EPS next 5Y	11.77%	ROE	-	52W High	25.10 -7.59%	Perf Year	142.12%
Cash/sh	4.09	P/FCF	14.58	EPS past 3/5Y	-77.99% -56.08%	ROIC	111.25%	52W Low	7.33 216.44%	Perf 3Y	44.07%
Dividend Est.	-	EV/EBITDA	8.53	Sales past 3/5Y	14.52% 8.64%	Gross Margin	86.02%	Volatility	3.12% 2.90%	Perf 5Y	207.22%
Dividend TTM	-	EV/Sales	2.34	EPS Y/Y TTM	168.96%	Oper. Margin	27.02%	ATR (14)	0.72	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.76	Sales Y/Y TTM	2.27%	Profit Margin	7.59%	RSI (14)	51.01	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.90	EPS Q/Q	118.01%	SMA20	-4.05%	Beta	1.02	Target Price	29.17
Payout	0.00%	Debt/Eq	-	Sales Q/Q	1.00%	SMA50	11.68%	Rel Volume	0.49	Prev Close	23.21
Employees	1051	LT Debt/Eq	-	Earnings	Jul 31 BMO	SMA200	70.08%	Avg Volume	2.92M	Price	23.19
IPO	Dec 29, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	96.15% 23.52%	Trades		Volume	1,436,026	Change	-0.06%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Initiated	H.C. Wainwright	Buy	$27
Jul-22-25	Resumed	Jefferies	Buy	$20
Jan-28-25	Initiated	Rodman & Renshaw	Buy	$16
Jul-23-24	Initiated	Piper Sandler	Overweight	$22
Apr-03-24	Initiated	Craig Hallum	Buy	$37
Jul-13-23	Initiated	Northland Capital	Outperform	$35

Sep-10-25 12:00PM	What Makes Indivior PLC (INDV) a Strong Momentum Stock: Buy Now? (Zacks)
Sep-09-25 11:57AM	Top 100 Stocks to Buy: Indivior Advances Into Top 50 on Momentum (Barchart)
Aug-20-25 12:00PM	Indivior to Participate in Upcoming Investor Events (PR Newswire)
Aug-06-25 09:36AM	Snap downgraded, Leidos upgraded: Wall Street's top analyst calls (The Fly)
Aug-05-25 12:00PM	All You Need to Know About Indivior (INDV) Rating Upgrade to Strong Buy (Zacks)
10:00AM	Loading…
10:00AM	Best Momentum Stock to Buy for August 5th (Zacks)
06:16AM	New Strong Buy Stocks for August 5th (Zacks)
Aug-03-25 12:32PM	Indivior Plc (INDV) Jumps 22.8% on Impressive Earnings, Outlook (Insider Monkey)
Aug-01-25 01:23PM	Indivior (INDV) Extends Jump on 3rd Day with 16% Gain (Insider Monkey)
Jul-31-25 08:15AM	Indivior PLC (INDV) Tops Q2 Earnings and Revenue Estimates (Zacks) +16.09%
07:00AM	Indivior Reports Second Quarter 2025 Financial Results and Raises FY 2025 Financial Guidance (PR Newswire)
Jul-30-25 09:43AM	Indivior PLC (INDV) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jul-28-25 10:06AM	Indivior PLC (INDV) Reinvents Leadership, Moves Listing to Nasdaq (Insider Monkey)
10:00AM	BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-25-25 02:00AM	Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained (PR Newswire)
10:00AM	Loading…
Jul-24-25 10:00AM	Indivior PLC (INDV) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-23-25 08:00AM	Indivior Real World Evidence Study Finds Medications for Opioid Use Disorder, Particularly Extended-Release Buprenorphine, Reduced Odds of Emergency Department Visits for Patients with Opioid Use Disorder (PR Newswire)
Jul-17-25 09:00AM	Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on July 31st (PR Newswire)
Jul-08-25 08:00AM	Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs (PR Newswire)
Jul-01-25 07:05AM	Indivior (INDV) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Jun-30-25 07:00AM	Indivior Announces Inclusion in the U.S. Russell 2000 and 3000 Indexes (PR Newswire) +5.66%
Jun-27-25 05:45PM	IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
Jun-24-25 04:12PM	Indivior Appoints Tony Kingsley to the Board of Directors (PR Newswire)
02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
10:40AM	Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength? (Zacks)
07:56AM	RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
Jun-20-25 03:01AM	Addex Therapeutics Ltd (ADXN) Q1 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Jun-19-25 09:00AM	Indivior Presents New Data at CPDD Demonstrating that High Buprenorphine Exposure May Improve Treatment Outcomes in High Fentanyl Users (PR Newswire)
Jun-05-25 05:08AM	Wise Plans to Shift Main Listing to US in Latest London Loss (Bloomberg)
Jun-02-25 05:24AM	FTSE pharma giant joins London stock market exodus (The Telegraph)
02:00AM	Loading…
02:00AM	Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained (PR Newswire)
May-27-25 08:30AM	Indivior Announces Patrick Barry as Chief Commercial Officer (PR Newswire) +5.02%
May-13-25 10:00AM	Indivior to Participate in Upcoming Investor Events (PR Newswire)
May-01-25 10:27AM	New Study Highlights Monthly SUBLOCADE as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy (PR Newswire)
Apr-28-25 12:12PM	Indivior: Trying To Break Addiction (Seeking Alpha)
Apr-24-25 10:45AM	Indivior PLC (INDV) Q1 2025 Earnings Conference Call Transcript (Seeking Alpha) +13.86%
07:05AM	Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates (Zacks)
03:58AM	Indivior Q1 Net Income Declines; Net Revenue Down 6% (RTT News)
02:00AM	Indivior Announces Q1 2025 Financial Results (PR Newswire)
Apr-02-25 04:12AM	Indivior: A Complicated Story Of Both Declining Revenue And Strong Financials (Seeking Alpha)
Mar-31-25 07:51PM	Is Indivior PLC (INDV) the Best Stock to Buy According to Howard Marks' Oaktree Capital Management? (Insider Monkey)
Mar-27-25 05:35PM	Plus Therapeutics (PSTV) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-04-25 08:40AM	Indivior Announces Further Changes to Board of Directors (PR Newswire) +5.76%
Mar-02-25 06:36PM	Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now? (Insider Monkey)
Feb-27-25 02:00AM	Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer (PR Newswire)
Feb-24-25 02:00AM	Indivior Announces FDA Approval of Label Changes for SUBLOCADE (buprenorphine extended-release) Injection (PR Newswire)
Feb-21-25 02:05AM	Indivior PLC (INDV) (Q4 2024) Earnings Call Highlights: Strong SUBLOCADE Growth and Strategic ... (GuruFocus.com) -6.01%
Feb-20-25 02:13PM	European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat (Benzinga) -17.60%
09:11AM	Earnings To Watch: Indivior PLC (INDV) Reports Q4 2024 Result (GuruFocus.com)
07:05AM	Indivior PLC (INDV) Q4 Earnings Meet Estimates (Zacks)
02:00AM	Indivior Announces FY and Q4 2024 Financial Results (PR Newswire)
Feb-13-25 10:01AM	Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-12-25 02:00AM	Indivior Statement RE: Delayed FDA Approval of SUBLOCADE Label Changes (PR Newswire)
Jan-31-25 08:33AM	Heres Summers Value Partners Investment Thesis for Indivior (INDV) (Insider Monkey)
Nov-23-24 02:01AM	Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ... (GuruFocus.com)
Nov-19-24 12:52PM	Rapid Initiation with Once-monthly SUBLOCADE Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024 (PR Newswire)
Nov-07-24 02:24PM	Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior (PR Newswire) +16.34%
Oct-30-24 12:30PM	Indivior Highlights Growing Body of Data on SUBLOCADE (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month (PR Newswire)
Oct-25-24 03:07AM	Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ... (GuruFocus.com)
Oct-24-24 07:05AM	Indivior PLC (INDV) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
02:00AM	Indivior Announces Q3 2024 Financial Results (PR Newswire)
Oct-23-24 09:09AM	Indivior PLC (INDV) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Oct-17-24 05:03PM	Two Seas Capital LP Increases Stake in Indivior PLC (GuruFocus.com) +5.53%
Oct-12-24 08:35AM	Indivior price target lowered to $16 from $20 at Craig-Hallum (TipRanks)
Oct-11-24 03:00AM	Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Navigating Competitive Pressures and ... (GuruFocus.com) -6.52%
Oct-10-24 09:28AM	Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details (Benzinga) -15.47%
07:00AM	Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion (PR Newswire)
Oct-07-24 11:30AM	Indivior's SUBLOCADE Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review (PR Newswire)
Oct-01-24 03:00AM	Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ... (GuruFocus.com)
Sep-23-24 02:00PM	Top 3 Health Care Stocks That May Explode This Month (Benzinga)
Sep-17-24 08:30AM	Indivior PLC Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INDV (PR Newswire)
Sep-13-24 05:45AM	Indivior PLC Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights - INDV (PR Newswire)
Sep-11-24 08:15AM	Indivior PLC Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INDV (PR Newswire)
Sep-06-24 05:45AM	Shareholders of Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights - INDV (PR Newswire) -6.67%
Sep-04-24 02:00AM	Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder (PR Newswire)
Aug-27-24 08:48AM	Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder (Benzinga)
Aug-26-24 10:30AM	Indivior Announces BARDA's First Order of OPVEE to Combat Opioids and Aid in National Preparedness (PR Newswire)
Aug-08-24 12:38PM	Shareholders of Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights INDV (GlobeNewswire)
Jul-26-24 10:44AM	Indivior reaches $86 million opioid settlement with 16 US states (Reuters)
Jul-25-24 07:05AM	Indivior PLC (INDV) Q2 Earnings and Revenues Beat Estimates (Zacks) +20.31%
02:10AM	Indivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame (PR Newswire)
02:00AM	Indivior Announces Q2 2024 Financial Results (PR Newswire)
Jul-18-24 10:01AM	Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-10-24 12:57PM	Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View (Zacks)
Jul-09-24 08:25AM	Why Is Indivior (INDV) Stock Down 37% Today? (InvestorPlace) -33.57%
07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
02:00AM	Indivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT (PR Newswire)
Jul-03-24 02:39PM	Indivior CEO Expects Ongoing U.S. Opioid Crisis to Drive Sales Growth (The Wall Street Journal)
Jun-18-24 03:40PM	Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Cardiac Arrest (PR Newswire)
Jun-10-24 02:30PM	Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder (PR Newswire)
May-24-24 09:06AM	Indivior CEO Mark Crossley on combatting the opioid crisis with new drugs (CNBC TV)
May-23-24 07:02AM	Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance (PR Newswire)
Apr-26-24 01:01PM	Indivior PLC (INDV) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
Apr-25-24 07:53AM	INDV Stock Earnings: Indivior Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -8.29%
07:05AM	Indivior PLC (INDV) Q1 Earnings and Revenues Lag Estimates (Zacks)
04:38AM	UPDATE 1-UK-listed drugmaker Indivior seeks shareholder nod for US listing (Reuters)
03:48AM	Drugmaker Indivior to seek shareholder nod on shifting primary listing to US (Reuters)
03:44AM	Indivior Confirms Plan to Switch Listing From London to New York (Bloomberg)
02:00AM	Indivior Announces Q1 2024 Financial Results (PR Newswire)
Apr-04-24 09:27AM	Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains? (Zacks)

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Crossley Mark	Affiliate	Sep 08 '25	Proposed Sale	24.75	26,463	655,000	Sep 08 04:26 PM
Mark Crossley	affiliate	Sep 08 '25	Proposed Sale	24.97	183,938	4,593,151	Sep 08 02:24 PM
Mark Crossley	affiliate	Sep 04 '25	Proposed Sale	24.80	30,000	744,010	Sep 04 12:59 PM
Mark Crossley	affiliate	Aug 28 '25	Proposed Sale	24.43	52,320	1,278,178	Aug 28 12:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INDV

Indivior Plc

Upgrade your FINVIZ experience